Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 21940214

CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2011 Oct
First author
Pfreundschuh M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2011 Oct;12(11):984-5. doi: 10.1016/S1470-2045(11)70251-0.
    note
    Source null
    related pmid
    21940215
    relationship
    Comment in

Authors and identifiers

  1. name
    Pfreundschuh M
    type
    Author
  2. name
    Kuhnt E
    type
    Author
  3. name
    Trümper L
    type
    Author
  4. name
    Osterborg A
    type
    Author
  5. name
    Trneny M
    type
    Author
  6. name
    Shepherd L
    type
    Author
  7. name
    Gill DS
    type
    Author
  8. name
    Walewski J
    type
    Author
  9. name
    Pettengell R
    type
    Author
  10. name
    Jaeger U
    type
    Author
  11. name
    Zinzani PL
    type
    Author
  12. name
    Shpilberg O
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Pfreundschuh M
    type
    Author
  2. name
    Kuhnt E
    type
    Author
  3. name
    Trümper L
    type
    Author
  4. name
    Osterborg A
    type
    Author
  5. name
    Trneny M
    type
    Author
  6. name
    Shepherd L
    type
    Author
  7. name
    Gill DS
    type
    Author
  8. name
    Walewski J
    type
    Author
  9. name
    Pettengell R
    type
    Author
  10. name
    Jaeger U
    type
    Author
  11. name
    Zinzani PL
    type
    Author
  12. name
    Shpilberg O
    type
    Author
bibliography ids
  1. nci-bib-e2e2c9c8d2279048549c921f
book metadata
content sha256
ee16c7959d4310e0536e686935d142cf5016724274eb74479c738d0aa55e1cf6
document type
citation
dois
  1. 10.1016/S1470-2045(11)70235-2
electronic publication date
display
2011 Sep 21
precision
day
year
2011
evidence scope
bibliographic_metadata_only
id
pubmed:21940214
immutable id
pubmed:21940214@ee16c7959d4310e0536e686935d142cf5016724274eb74479c738d0aa55e1cf6
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
11
name
The Lancet. Oncology
nlm unique id
100957246
pages
1013-22
volume
12
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2011 Oct;12(11):984-5. doi: 10.1016/S1470-2045(11)70251-0.
    note
    Source null
    related pmid
    21940215
    relationship
    Comment in
outcomes validated
false
pmid
21940214
provenance
batch id
2529ef2eca926738ab13
provider
NCBI PubMed ESummary
record sha256
73fa347a8f30d316d4ca67815495d802b7005cea6f4b1bd7e7972f38af293a29
response sha256
9204e3dd8d67df5a6773613a8059d8d42d9842ee24eecc9b0f39a62f636c99b6
retrieved at
2026-09-09T23:46:42.856296+00:00
publication date
display
2011 Oct
precision
month
year
2011
publication types
  1. Journal Article
  2. Multicenter Study
  3. Randomized Controlled Trial
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/21940214/
title
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group.

Preserved source evidence · Independent clinical review pending · Not medical advice